COMMUNIQUÉS West-GlobeNewswire

Lisata Therapeutics Announces First Patient Treated in the Phase 2a Trial of LSTA1 in Patients with Glioblastoma Multiforme

17/01/2024 - 14:00

BASKING RIDGE, N.J., Jan. 17, 2024 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of [...]

Gamida Cell to Present at the 2024 Tandem Meetings of ASTCT® and CIBMTR®

17/01/2024 - 14:00

BOSTON, Jan. 17, 2024 (GLOBE NEWSWIRE) -- Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today announced it will present new data on its FDA approved allogeneic [...]

BioAdaptives Announces Signing of a New Distributor’s Agreement for AI Body Composition Measuring App and New Weight Management System

17/01/2024 - 14:00

FIT YOUR OUTFIT (FYO) the App That Scientifically Measures and Tracks Body Composition With A SINGLE PHOTO FROM YOUR SMARTPHONE LAS VEGAS, NV, Jan. 17, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – BioAdaptives, Inc. ( [...]

Aclarion Announces Updated Product Release That Expands MRI Scanner Access for Nociscan Solution

17/01/2024 - 14:00

Nociscan is the first augmented intelligence platform to measure pain biomarkers in the lumbar spine This new product release expands accessibility of Nociscan on the worldwide MR market Builds on preexisting [...]

Jack Ride 15 Brings Community Together to End the Youth Mental Health Emergency

17/01/2024 - 14:00

Jack.org invites you to join Canada’s Ride for Youth Mental Health and support life-changing youth mental health programs in communities across Canada TORONTO, Jan. 17, 2024 (GLOBE NEWSWIRE) -- Jack.org, a leading [...]

La Jack Ride 15 Mobilise La Communauté Pour Mettre Fin À La Crise En Santé Mentale Des Jeunes

17/01/2024 - 14:00

Jack.org vous invite à Rouler pour la santé mentale des jeunes et à soutenir les programmes de qui s’y rapportent; programmes porteurs de changement dans les communautés canadiennes. TORONTO, 17 janv. 2024 (GLOBE [...]

ZyVersa Therapeutics Highlights Peer-Reviewed Article Linking Inflammasome Activation to Triple-Negative Breast Cancer Brain Metastasis

17/01/2024 - 13:52

Up to 40% of women with triple negative breast cancer (TNBC) experience metastasis to their brain, which affects physical function, independence, personality, quality of life, and significantly increases mortality rates [...]

DiagnaMed Announces Pilot Launch of CERVAI™ Brain Health AI Solution

17/01/2024 - 13:30

TORONTO, Jan. 17, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a digital health artificial intelligence company focused on brain health, today announced [...]

Venus Concept Launches Venus Prime

17/01/2024 - 13:30

TORONTO, Jan. 17, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ: VERO), a global medical aesthetic technology leader, announced today the launch of Venus Prime, a structured in- [...]

Manitoba Harvest Hemp Foods Celebrates a Decade of B Corp Certification With a Score of 100 Points

17/01/2024 - 13:03

Leading Global Hemp Foods Brand Reinforces their Commitment to the Global B Corp Community NEW YORK and WINNIPEG, Manitoba, Jan. 17, 2024 (GLOBE NEWSWIRE) -- Manitoba Harvest , a pioneer and leader in hemp-based foods [...]

First Wave BioPharma CEO to Present at the Sequire Investor Summit 2024 in Puerto Rico

17/01/2024 - 13:00

BOCA RATON, Fla., Jan. 17, 2024 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of [...]

Mary Beth DeLena Joins PepGen as General Counsel and Secretary

17/01/2024 - 13:00

BOSTON, Jan. 17, 2024 (GLOBE NEWSWIRE) -- PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of [...]

Gritstone bio to Participate in Upcoming Investor Conference

17/01/2024 - 13:00

EMERYVILLE, Calif., Jan. 17, 2024 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, today announced that management will [...]

Comanche Biopharma Closes Oversubscribed $75 Million Series B Financing to Advance Mission to Develop and Make Globally Available the First Treatment Targeting a Root Cause of Preeclampsia

17/01/2024 - 12:00

Financing was led by New Enterprise Associates (NEA) and closed with additional new investor Atlas Venture and continued investment by GV and F-Prime Capital Significant investment by top-tier syndicate endorses [...]

MediciNova Receives a Notice of Grant for a New Patent Covering MN-166 (ibudilast) for the Treatment of Macular Injury in China

17/01/2024 - 12:00

LA JOLLA, Calif., Jan. 17, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875 [...]

Samsung Bioepis Releases First Quarter 2024 US Biosimilar Market Report

17/01/2024 - 08:00

Report highlights latest biosimilar pricing and market share status, including state of the adalimumab market Biosimilar Deep Dive section illustrates patient benefit from lower adalimumab cost options using the [...]

Postponement of the decision on the adoption of a sale plan (plan de cession) and the opening of judicial liquidation proceedings

17/01/2024 - 07:00

Postponement of the decision on the adoption of a sale plan ( plan de cession ) and the opening of judicial liquidation proceedings Paris, France, January 17, 202 4 – 7:00 am (CET) – Pixium Vision SA (Euronext Growth [...]

Report de la décision concernant l’arrêté d’un plan de cession et l’ouverture d’une procédure de liquidation judiciaire

17/01/2024 - 07:00

Report de la décision concernant l’arrêté d’un plan de cession et l’ouverture d’une procédure de liquidation judiciaire Paris, France, 17 janvier 2024 – 07h00 CET – Pixium Vision SA (Euronext Growth Paris – FR001400JX97 [...]

Vision Sensing Acquisition Corp. Announces Definitive Agreement and Plan of Merger with Mediforum Co., Ltd

16/01/2024 - 23:33

The Combined Company Is Expected To Trade On Nasdaq Post-Closing Under A New Ticker Symbol Mediforum is a leading biotechnology company in Korea that focuses on researching and developing ethical drugs and diagnostic [...]